US Patent Number

6403619

Publication Date

6-11-2002

Abstract

The invention relates to the manipulation of enzymatic pathways, such as poly (ADP-ribose) polymerase pathways, which are dependent upon NAD as a substrate. By administering pro-NAD compounds, cell death caused by necrosis and/or apoptosis can be reduced. Further, by inhibiting one or more of these enzymes, the process of cell death can be accelerated, in conditions such as cancer, where acceleration of cellular necrosis and/or apoptosis is desired. Various inhibitors are described.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

09/549,691

Filing Date

04/14/2000

Share

COinS